The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Minocycline Reduces Microglial Activation and Improves Behavioral Deficits in a Transgenic Model of Cerebral Microvascular Amyloid
Open accessAbstract
Cerebral microvascular amyloid β protein (Aβ) deposition and associated neuroinflammation is increasingly recognized as an important component leading to cognitive impairment in Alzheimer's disease and related cerebral amyloid angiopathy disorders. Transgenic mice expressing the vasculotropic Dutch/Iowa (E693Q/D694N) mutant human Aβ precursor protein in brain (Tg-SwDI) accumulate abundant cerebral microvascular fibrillar amyloid deposits and exhibit robust neuroinflammation. In the present study, we investigated the effect of the anti-inflammatory drug minocycline on Aβ accumulation, neuroinflammation, and behavioral deficits in Tg-SwDI mice. Twelve-month-old mice were treated with saline or minocycline by intraperitoneal injection every other day for a total of 4 weeks. During the final week of treatment, the mice were tested for impaired learning and memory. Brains were then harvested for biochemical and immunohistochemical analysis. Minocycline treatment did not alter the cerebral deposition of Aβ or the restriction of fibrillar amyloid to the cerebral microvasculature. Similarly, minocycline-treated Tg-SwDI mice exhibited no change in the levels of total Aβ, the ratios of Aβ40 and Aβ42, or the amounts of soluble, insoluble, or oligomeric Aβ compared with the saline-treated control Tg-SwDI mice. In contrast, the numbers of activated microglia and levels of interleukin-6 were significantly reduced in minocycline-treated Tg-SwDI mice compared with saline-treated Tg-SwDI mice. In addition, there was a significant improvement in behavioral performance of the minocycline-treated Tg-SwDI mice. These finding suggest that anti-inflammatory treatment targeted for cerebral microvascular amyloid-induced microglial activation can improve cognitive deficits without altering the accumulation and distribution of Aβ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Memory deficits associated with senescence: A neurophysiological and behavioral study in the rat.
Barnes, C. A. (1979) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0077579 · Cited by 2,088
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207 · cited 1×
“Characteristic features of Alzheimer’s disease (AD) include cognitive decline, amyloid -peptide (A ) deposition, formation of neurofibrillary tangles, and increase of inflammatory cells and molecules (Selkoe, 2001; Walsh and Selkoe, 2004).”
BackgroundLRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms
Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828
Self-citationCombs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721
Alzheimer disease and cerebrovascular pathology: an update
Jellinger, K. A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200068 · Cited by 680 · cited 1×
“In addition to parenchymal plaques, fibrillar A deposition in the cerebral vasculature, a condition known as cerebral amyloid angiopathy (CAA), is commonly found in AD (Jellinger, 2002; Rensink et al., 2003; Zhang-Nunes et al., 2006).”
BackgroundGrabowski, T. J., Cho, H. S., Vonsattel, J. P. G., Rebeck, G. W., & Greenberg, S. M. (2001) · Annals of Neurology · doi:10.1002/ana.1009 · Cited by 523
Clinical manifestations of cerebral amyloid angiopathy–related inflammation
Eng, J. A., Frosch, M. P., Choi, K., Rebeck, G. W., & Greenberg, S. M. (2004) · Annals of Neurology · doi:10.1002/ana.10810 · Cited by 417 · cited 4×
“Recent studies have implicated cerebral microvascular A deposition in promoting neuroinflammation and dementia in AD and related familial CAA disorders (Vinters, 2001; Thal et al., 2003; Atterns and Jellinger, 2004; Bailey et al., 2004; Eng et al., 2004; Greenberg et al., 2004).”
BackgroundInfluentialThal, D. R., Ghebremedhin, E., Orantes, M., & Wiestler, O. D. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1287 · Cited by 384 · cited 1×
“Recent studies have implicated cerebral microvascular A deposition in promoting neuroinflammation and dementia in AD and related familial CAA disorders (Vinters, 2001; Thal et al., 2003; Atterns and Jellinger, 2004; Bailey et al., 2004; Eng et al., 2004; Greenberg et al., 2004).”
BackgroundDavis, J., Xu, F., Deane, R., Romanov, G., Previti, M. L., Zeigler, K., Zlokovic, B. V., & Van Nostrand, W. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312946200 · Cited by 373 · cited 3×
“DOI:10.1523/JNEUROSCI.4371-06.2007 Copyright © 2007 Society for Neuroscience 0270-6474/07/273057-07$15.00/0 ture (Davis et al., 2004, 2006; Deane et al., 2004; Miao et al., 2005a).”
BackgroundSelf-citationDeMattos, R. B., O'dell, M. A., Parsadanian, M., Taylor, J. W., Harmony, J. A. K., Bales, K. R., Paul, S. M., Aronow, B. J., & Holtzman, D. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162228299 · Cited by 359
Microglia and Alzheimer's disease pathogenesis
Streit, W. J. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20093 · Cited by 335
The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease
Bailey, T. L., Rivara, C. B., Rocher, A. B., & Hof, P. R. (2004) · Neurological Research · doi:10.1179/016164104225016272 · Cited by 213 · cited 1×
“Recent studies have implicated cerebral microvascular A deposition in promoting neuroinflammation and dementia in AD and related familial CAA disorders (Vinters, 2001; Thal et al., 2003; Atterns and Jellinger, 2004; Bailey et al., 2004; Eng et al., 2004; Greenberg et al., 2004).”
BackgroundQuintero, E. M., Willis, L., Singleton, R., Harris, N., Huang, P., Bhat, N., & Granholm, A.-C. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.104 · Cited by 58 · cited 2×
“In animal models of neurological diseases such as Parkinson’s disease (Quintero et al., 2006), Huntington’s disease (Pattison et al., 2006), amyotrophic lateral sclerosis (Zhu et al., 2002), and Down’s syndrome (Hunter et al., 2004), minocycline treatment has been reported to ameliorate symptoms,…”
Background
Cited by
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
“The treatment significantly improves the behavioral performance of transgenic mice expressing the mutant human Aβ precursor protein [ 77 ].”
BackgroundMicroglia Regulate the Number of Neural Precursor Cells in the Developing Cerebral Cortex
Cunningham, C. L., Martínez-Cerdeño, V., & Noctor, S. C. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3441-12.2013 · Cited by 976
“We also tested the capacity of minocycline to deactivate microglia in the prenatal cerebral cortex, since previous work has shown that minocycline reduces the activation state of microglia (Yrjänheikki et al., 1998; Tikka et al., 2001; Ekdahl et al., 2003; Fan et al., 2007).”
ResultRole of interleukin‐1β in postoperative cognitive dysfunction
Cibelli, M., Fidalgo, A. R., Terrando, N., Ma, D., Monaco, C., Feldmann, M., Takata, M., Lever, I. J., Nanchahal, J., Fanselow, M. S., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22082 · Cited by 740
Rajmohan, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160612 · Cited by 688
Immune activation in brain aging and neurodegeneration: too much or too little?
Lucin, K. M., & Wyss-Coray, T. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.039 · Cited by 679
Metadata
- Authors
- Fan, R., Xu, F., Previti, M. L., Davis, J., Grande, A. M., Robinson, J. K., & Van Nostrand, W. E.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-03-21
- Volume
- 27
- Issue
- 12
- Pages
- 3057-3063
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2036983527
- Cited by
- 196
- References
- 14
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.